Dr. Gary Lyman, MPH, FASCO, FRCP, joins ASCO CEO Dr. Clifford A. Hudis to discuss biosimilars and ASCO's recent statement on biosimilars published in the Journal of Clinical Oncology.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
